-
AIOCD asks members to strengthen cold chain capabilities for COVID-19 vaccines
expresspharma
November 25, 2020
The All India Organisation of Chemists & Druggists (AIOCD) has asked its members to ensure that their refrigerators are in full working condition with power backup and adheres with cold chain requirements for the storage of COVID-19 vaccine.
-
UK and US could administer first approved COVID-19 vaccines next month
europeanpharmaceuticalreview
November 24, 2020
Both the UK and US have said that, if approved, the Pfizer and BioNTech COVID-19 vaccine could be administered to people as early as December.
-
AZ/Oxford University’s COVID-19 vaccine shows average efficacy of 70%
pharmatimes
November 24, 2020
AstraZeneca (AZ) and Oxford University’s COVID-19 vaccine candidate AZD1222 has scored an average efficacy rate of 70% in an interim analysis of phase II/III trials conducted in the UK and Brazil.
-
Pfizer, BioNTech Submit EUA Request for COVID-19 Vaccine
americanpharmaceuticalreview
November 24, 2020
Pfizer and BioNTech announced they will submit a request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of their mRNA vaccine candidate, BNT162b2 against SARS-CoV-2, which will potentially enable use of the vaccine ..
-
AstraZeneca COVID-19 vaccine shows 90 per cent efficacy
expresspharma
November 24, 2020
AZD1222, given as a half dose, followed by a full dose at least one month apart, showed vaccine efficacy of 90 per cent while it showed 62 per cent efficacy when given as two full doses at least one month apart.
-
Demand for repurposed drugs to continue even after launch of COVID-19 vaccines: Experts
expresspharma
November 24, 2020
Due to the large size of the population in the country and anticipated challenges associated with the COVID-19 vaccine supply chain, it will take considerable time until the entire nation gets vaccinated.
-
Pfizer-BioNTech COVID-19 vaccine may create set of firsts for pharma sector: GlobalData
expresspharma
November 23, 2020
In modern history, no vaccine has ever been considered as essential to restoring normality to our way of life as these first mRNA vaccines, says analyst.
-
Britain may approve COVID-19 vaccine from Pfizer-BioNTech this week, reports Telegraph
expresspharma
November 23, 2020
Britain could give regulatory approval to Pfizer-BioNTech’s COVID-19 vaccine this week, even before the US authorises it, the Telegraph news site reported.
-
EDQM releases new guidelines for COVID-19 vaccine quality testing
europeanpharmaceuticalreview
November 20, 2020
The European Directorate for the Quality of Medicines & Healthcare has announced three new guidelines outlining how to test the quality of COVID-19 vaccines.
-
Johnson & Johnson gets approval for Phase III Covid-19 vaccine trial in Spain
pharmaceutical-technology
November 20, 2020
The Spanish Agency for Medicines and Health Products (AEMPS) has authorised the initiation of Phase III trials of Johnson & Johnson (J&J) unit Janssen’s Covid-19 vaccine in the country.